Table 2.
1996–1997 | 2001–2003 | |||||
Genotype | All patients | Survivors | Non-survivors | All patients | Survivors | Non-survivors |
G4/G4 | 8 (18%) | 6 (14%) | 2 (5%) | 33 (22%) | 32 (21%) | 1 (1%) |
G4/G5 | 15 (34%) | 11 (25%) | 4 (9%) | 62 (41%) | 60 (40%) | 2 (1%) |
G5/G5 | 21 (48%) | 15 (34%) | 6 (14%) | 55 (37%) | 53 (35%) | 2 (1%) |
Total | 44 (100%) | 32 (73%) | 12 (27%) | 150 (100%) | 145 (97%) | 5 (3%) |